Skip to content
CheckOrphan
  • Home
  • About Us
  • Log In
  • News
    • All News
    • Finance
    • Treatment
    • People
    • Research
  • Videos
  • Treatments
  • Clinical Trials
  • Access Programs
    • About Access Programs
  • Diseases
  • Events
  • Networks
  • Research
Main Menu

Subscribe for Free Newsletter

Email *

Type *

* Required Field
Email Marketing Services by Benchmark

Generate RSS

  1. Home
  2. /
  3. Clinical Trial
  4. /
  5. Study Of Palbociclib Combined...

Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

May 27, 2020checkorphan
Learn more about:
Rhabdoid tumor
Related Clinical Trial
A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors

Recruitment Information

Administrative Informations

Related News

  • Lantern Pharma’s LP-184 Shows Promise in Atypical Teratoid Rhabdoid
  • Epigenetic combination therapy could overcome treatment resistance in
  • New insights into the development of Rhabdoid tumors
  • Saol Therapeutics enhances its IP portfolio for Dichloroacetate (DCA;
More News

Related Clinical Trial

  • A Study of Panobinostat in Pediatric Patients With Solid Tumors Includ
More Clinical Trial

Related

  • Lantern Pharma’s LP-184 Shows Promise in Atypical Teratoid Rhabdoid
  • Epigenetic combination therapy could overcome treatment resistance in
  • New insights into the development of Rhabdoid tumors
  • Saol Therapeutics enhances its IP portfolio for Dichloroacetate (DCA;
  • A Study of Panobinostat in Pediatric Patients With Solid Tumors Includ
  • Rhabdoid tumor
More
pw

About CheckOrphan

CheckOrphan is a non-profit organization located in Basel, Switzerland and Santa Cruz, California that is dedicated to rare, orphan and neglected diseases. CheckOrphan offers users an interactive and dynamic platform for all these diseases. This strategy allows visitors to be updated daily on all the latest news and interact with people internationally. This is essential, because due to the nature of these diseases, there is not a large concentration of individuals within any given proximity.
Click here to know more About Us

Your email is important to us

Each email is sent to a CheckOrphan staff member and will be answered. We only use a contact form to avoid spam.

    Copyright © 2025 CheckOrphan.
    Developed by: Gonza.io logo Developed by: WebOptimalSolutions Powered by: Cloudscale logo